Accessibility Menu
Quest Diagnostics logo

Quest Diagnostics(NYSE) DGX

Market Cap$26.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)+9,726%
5 Year+72%
1 Year+35%
1 Month+3%
Premium Feature
Moneyball Superscore
75/100
$240.73
-0.84%
-2.03Today
After hours$242.50+$1.77 (+0.74%)
Quest Diagnostics last closing stock price
MetricPriceDate
Last closeUSD 240.302026-08-31
Quest Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.46%USD 243.872026-08-24
1 month+3.13%USD 233.012026-07-31
3 month+24.91%USD 192.382026-06-02
Year to date+40.28%USD 171.292025-12-31
1 year+34.62%USD 178.512025-08-29
3 year+95.26%USD 123.072023-09-01
5 year+72.48%USD 139.322021-09-01
Since inception+9,725.57%USD 2.471996-12-17

Quest Diagnostics Financials at a Glance

Market Cap

$26.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.56B

Net Income (TTM)

$1.06B

EPS (TTM)

$9.43

P/E Ratio

25.49

Dividend

$3.32

Beta (Volatility)

0.35 (Low)

Price

$240.73

Volume

1,358,258.226

Open

$241.99

Previous Close

$240.30

Daily Range

$239.40 - $242.64

52-Week Range

$171.18 - $247.19

Estimated Earnings Date

Oct 20, 2026

DGX News

Doctor holding clipboard stands with virtual DNA double helix in the air near him.

7 Best Genomics Stocks for 2026 and How to Invest

Lyle DalyAug 17, 2026
Medical researchers -GettyImages-1060970374

Why Quest Diagnostics Stock Climbed This Past Week

Joe TenebrusoJul 26, 2026
Cannabis greenhouse.

5 Best Marijuana Stocks for 2026 and How to Invest

Keith SpeightsJul 14, 2026
maxresdefault (1)

Quest Diagnostics: A Solid Investment or a Risky Bet?

Motley Fool YouTubeSep 4, 2025
Foolcom-Featured.png

Quest Diagnostics Raises 2025 Guidance

Motley Fool Markets TeamJul 22, 2025
featured-earnings-leadership-highlights.png

Quest Diagnostics Boosts Its 2025 Outlook

Motley Fool Markets TeamJul 22, 2025
Person using a diagnostic health test

Why Quest Diagnostics Stock Was Blasting Higher Today

Eric VolkmanJan 30, 2025
GettyImages-1460419757-600x400-bf06395.jpg

Quest Diagnostics EPS Tops Predictions

Motley Fool Markets TeamJan 30, 2025
Page 1

DGX: Motley Fool Moneyball Superscore

75

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quest Diagnostics

Quest Diagnostics Incorporated tests blood samples for doctors. These tests help people find and treat diseases early. The company also makes software for hospital health data.

What Does Quest Do?

  • Diagnostic Information Services: Lab testing for doctors, hospitals, and patients including routine and advanced pathology, which is the study of tissues and fluids; accounts for more than 95% of net revenues.
  • Risk Assessment Services: Solutions for life insurance companies to help them evaluate health risks for new insurance applicants.
  • Healthcare Information Technology: Software systems for clinicians and health plans to manage patient data, billing, and order processing.

Growing the Network

  • Formed a new entity with Corewell Health in Jan. 2026 to provide lab testing services in Michigan.
  • Increased testing volume through an expanded relationship with dialysis clinics owned by Fresenius Medical Care.
  • Completed a $500 million senior notes offering in May 2026 to pay down existing debt.
  • Authorized an additional $1 billion for the repurchase of common stock in Feb. 2026.

Modernizing for the Future

The company uses its Invigorate program to automate laboratory operations and improve productivity, aiming for 3% annual cost savings. It also runs Project Nova to modernize technology systems and improve patient experiences during the testing process.

Key Financial Results

  • Net revenues reached $3.04 billion for the three months ended June 30, 2026, up 10.2% year over year.
  • Net income was $320 million for the three months ended June 30, 2026, up 13.4% year over year.
  • Net cash from operations reached $875 million for the six months ended June 30, 2026, up $17 million year over year.
  • Diluted earnings per share were $2.84 for the three months ended June 30, 2026, up 15.0% year over year.

Bottom Line

Quest has evolved from a laboratory provider into a health information company. Its use of automated technology and large-scale data supports its central role in the domestic healthcare system.

AI Generated • Jul 24, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

57,000

CEO

James E. Davis

Website

www.questdiagnostics.com

Headquarters

Secaucus, NJ 07094, US

DGX Financials

Key Financial Metrics (TTM)

Gross Margin

33.15%

Operating Margin

14.14%

Net Income Margin

9.19%

Return on Equity

14.49%

Return on Capital

11.38%

Return on Assets

6.27%

Earnings Yield

3.92%

Dividend Yield

1.38%

Payout Ratio

34.18%

Stock Overview

Market Cap

$26.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

110.37M

Volume

1.36M

Avg. Volume

935.38K

Financials (TTM)

Gross Profit

$3.83B

Operating Income

$1.64B

EBITDA

$2.01B

Operating Cash Flow

$1.77B

Capital Expenditure

-$554.00M

Free Cash Flow

$1.22B

Cash & ST Invst.

$626.00M

Total Debt

$6.38B

Quest Diagnostics Performance Analysis

Quest Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 9,883,000,000-8.4%
20232023-12-31USD 9,252,000,000-6.4%
20242024-12-31USD 9,872,000,0006.7%
20252025-12-31USD 11,035,000,00011.8%
Quest Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.0%
Q42025-12-31-0.4%
Q12026-03-313.2%
Q22026-06-305.1%
Quest Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 7.98-48.6%
20232023-12-31USD 7.52-5.8%
20242024-12-31USD 7.661.9%
20252025-12-31USD 8.7414.1%
Quest Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-12.6%
Q42025-12-310.9%
Q12026-03-312.8%
Q22026-06-3026.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.04B

+10.2%

Gross Profit

$1.03B

+8.9%

Gross Margin

33.75%

N/A

Market Cap

$26.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$515.00K

N/A

Employees

51,500

N/A

Net Income

$320.00M

+13.5%

EBITDA

$481.00M

-19.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$626.00M

+96.2%

Total Debt

$6.38B

-0.0%

Accounts Receivable

$1.67B

+17.4%

Inventory

$233.00M

+24.6%

Long Term Debt

$6.19B

+8.5%

Short Term Debt

$190.00M

-71.9%

Return on Assets

6.27%

N/A

Return on Invested Capital

10.79%

N/A

Free Cash Flow

$330.00M

-24.3%

Operating Cash Flow

$468.00M

-14.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LHLabcorp Holdings Inc.
$332.66-0.73%
INCYIncyte Corporation
$123.22-0.92%
WSTWest Pharmaceutical Services, Inc.
$341.11+1.08%
WATWaters Corporation
$414.63-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
WETOWetour Robotics
$5.48-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
INTCIntel
$89.51+0.00%
IBITiShares Bitcoin Trust
$44.67+0.02%

Questions About DGX

What is the current price of Quest Diagnostics?

Quest Diagnostics is trading at $240.30 per share.

What is the 52-week range for Quest Diagnostics?

Over the past 52 weeks, Quest Diagnostics has traded between $171.18 and $247.19.

How much debt does Quest Diagnostics have?

As of the most recent reporting period, Quest Diagnostics reported total debt of $6.38B.

How much cash does Quest Diagnostics have on hand?

Quest Diagnostics reported $626.00M in cash and cash equivalents in its most recent financial results.

What is Quest Diagnostics’s dividend yield?

Quest Diagnostics currently has a dividend yield of 1.38%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services